Widely prescribed blood pressure drugs linked to 33% higher kidney risk in type 2 diabetes
A widely prescribed blood pressure drug was associated with a 33% higher risk of serious kidney problems in people with type 2 diabetes, even when they were already taking kidney-protective medications. The surprising finding is prompting researchers to question whether DCCBs are always the safest second-line choice for diabetic kidney disease.
This is a summary aggregated from ScienceDaily. Read the complete article on the original site:
Read full article at ScienceDaily